Anticoagulation Reversal for ICH

June 24, 2019 00:26:09
Anticoagulation Reversal for ICH
Critical Care Perspectives in Emergency Medicine
Anticoagulation Reversal for ICH

Jun 24 2019 | 00:26:09

/

Show Notes

ICH accounts for approximately 15 percent of all strokes.  Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50 percent at 1-year, with many left with significant residual deficits.  Patients with an ICH who are taking an oral anticoagulant medication tend to have larger ICH volumes, more frequent IVH, and a greater frequency of hematoma expansion.  In this podcast, we review the latest recommendations on reversing anticoagulant medications in patients with an ICH. This is information you can’t afford to miss!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

April 17, 2019 00:22:01
Episode Cover

Tips for the Renal Transplant Patient

Renal transplants are one of the most common organ transplants worldwide.  Renal transplant patients can quickly succumb to illness and present to the ED...

Listen

Episode

June 07, 2024 00:22:24
Episode Cover

Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at...

Listen

Episode 0

May 13, 2020 00:21:18
Episode Cover

COVID-19: Toxicities of Potential Therapies

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence....

Listen